您的位置: 专家智库 > >

国家自然科学基金(30872292)

作品数:3 被引量:7H指数:1
相关作者:王应马大龙更多>>
相关机构:北京大学更多>>
发文基金:国家自然科学基金北京市自然科学基金国家高技术研究发展计划更多>>
相关领域:生物学医药卫生更多>>

文献类型

  • 3篇中文期刊文章

领域

  • 2篇生物学
  • 1篇医药卫生

主题

  • 3篇趋化
  • 2篇受体
  • 2篇趋化因子
  • 2篇趋化因子受体
  • 2篇细胞
  • 1篇蛋白
  • 1篇新细胞
  • 1篇新药
  • 1篇新药开发
  • 1篇性疾病
  • 1篇药物
  • 1篇药物发现
  • 1篇偶联
  • 1篇趋化素样因子
  • 1篇转染
  • 1篇转染细胞
  • 1篇自身免疫
  • 1篇自身免疫病
  • 1篇细胞因子
  • 1篇毛细管

机构

  • 1篇北京大学

作者

  • 1篇马大龙
  • 1篇王应

传媒

  • 1篇中国药学杂志
  • 1篇Scienc...
  • 1篇Journa...

年份

  • 2篇2011
  • 1篇2010
3 条 记 录,以下是 1-3
排序方式:
Rat CC chemokine receptor 4 is the functional homologue of human CC chemokine receptor 4 and can interact with human CCL17 and CCL22
2010年
Human CCL17/TARC (hCCL17) and CCL22/MDC (hCCL22) interact with their receptor CCR4, playing pivotal roles in various Th2 cell-dominant diseases. Rat Ccl17, Ccl22 and Ccr4 share 63.4%, 65.2% and 87.5% homology at the amino acid level, respectively, compared with their human homologues. Rat Ccl22 has been demonstrated to interact with rat Ccr4. However, it is not known whether rat Ccl17 is a functional ligand for rat Ccr4 and whether rat Ccr4 can interact with hCCL17 and hCCL22. In this study, we cloned rat Ccl17 and Ccr4 cDNA from rat thymus and expressed the recombinant rat Ccl17. The binding assay indicated rat Ccl17 could saturably bind rat Ccr4, and this binding could be competitively inhibited by unlabeled rat Cc17, hCCL17 or hCCL22. Both rat and human CCL17 or CCL22 could induce the chemotactic migration and calcium mobilization in rat Ccr4-transfected cells. They could also desensitize each other’s effect on chemotaxis and calcium mobilization. Furthermore, both rat Ccl17 and hCCL17 could induce significant receptor internalization in rat Ccr4-EGFP transfected cells. These results demonstrated the conserved CCL17/CCR4 interaction in rats and the further cross-species interaction of rat Ccr4 with hCCL17 and hCCL22. Likewise, they provided the molecular basis for the investigation of physiological and pharmacological roles of CCR4, its ligands, and their antagonists in rat disease models.
TIAN LinJie1,2, QI Hui1,2, XIE Yuan1,2, ZHANG YingMei1,2, ZHANG WenJuan1,2, SUN XiangYu1,2, WANG Ying1,2 & MA DaLong1,2 1 Laboratory of Medical Immunology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, China
关键词:趋化因子受体基因转染细胞
新细胞因子趋化素样因子(CKLF1)的发现与新药开发被引量:6
2011年
目的从人类基因组发现和开发新药靶标是新世纪药物开发的热点领域,并显现出良好的前景。本综述介绍作者实验室从人类基因组发现的新细胞因子趋化素样因子(chemokine-like factor 1,CKLF1),后续研究发现包括国内外多家实验室的研究工作。方法总经经过近10年的研究,包括国内外多家实验室细胞水平、动物体内及临床疾病相关性研究。结果 CK-LF1是一个新的非典型趋化因子,具有广谱的趋化活性,并发挥促进炎症的效应,而CKLF1的C端衍生肽CKLF1-C19是一个潜在的CKLF1拮抗肽。在小鼠哮喘模型中,CKLF1-C19可明显抑制Th2细胞和嗜酸性粒细胞在肺部的浸润,降低气道反应性。结论 CKLF1-C19有望成为新的抗炎多肽药物。
王应马大龙
关键词:细胞因子自身免疫病过敏性疾病
Screening of chemokine receptor CCR4 antagonists by capillary zone electrophoresis被引量:1
2011年
CC chemokine receptor 4(CCR4) is a kind of G-protein-coupled receptor,which plays a pivotal role in allergic inflammation.The interaction between 2-(2-(4-chloro-phenyl)-5-{[(naphthalen-1ylmethyl)-carbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-N-(3-morpholin-4-yl-propyl)-acetamide(S009) and the N-terminal extracellular tail(ML40) of CCR4 has been validated to be high affinity by capillary zone electrophoresis(CZE).The S009 is a known CCR4 antagonist.Now,a series of new thiourea derivatives have been synthesized.Compared with positive control S009,they were screened using ML40 as target by CZE to find some new drugs for allergic inflammation diseases.The synthesized compounds XJH-5,XJH-4,XJH-17 and XJH-1 displayed the interaction with ML40,but XJH-9,XJH-10,XJH-11,XJH-12,XJH-13,XJH-14,XJH-3,XJH-8,XJH-6,XJH-7,XJH-15,XJH-16 and XJH-2 did not bind to ML40.Both qualification and quantification characterizations of the binding were determined.The affinity of the four compounds was valued by the binding constant,which was similar with the results of chemotactic experiments.The established CEZ method is capable of sensitive and fast screening for a series of lactam analogs in the drug discovery for allergic inflammation diseases.
Zhe SunLin-Jie TianQian LinXiao-Mei LingJun-Hai XiaoYing Wang
关键词:趋化因子受体G蛋白偶联受体毛细管区带电泳药物发现
共1页<1>
聚类工具0